High-dose S(+)- ketamine improves neurological outcome following incomplete cerebral ischemia in rats

Canadian Journal of Anesthesia

Volumn 47, Issue 6, 2000, Pages 572-578

  Reeker, W ^a   Werner, C ^a   Mollenberg, O ^a   Mielke, L ^a   Kochs, E ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; KETAMINE; NITROUS OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG MEGADOSE; MALE; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPATHETIC TONE;

EID: 0033735572     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018950     Document Type: Article

References (30)

1. The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate
2. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist
3. Comparative pharmacology of the ketamine isomers. Studies in volunteers
4. Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man
5. Influence of racemic ketamine and S-(+)- ketamine on vigilance, performance and wellbeing. (German)
6. Ketamine decreases plasma catecholamines and improves outcome from incomplete cerebral ischemia in rats
7. Experimental studies on brain oedema after blunt head injury: Experimental approaches from animal experimentation to actual or possible clinical application
8. Ketamine decreases cerebral infarct volume and improves neurological outcome following experimental head trauma in rats
9. The effects of ketamine-isomers on neuronal injury and regeneration in rat hippocampal neurons
10. The effect of halothane and isoflurane on neurologic outcome following incomplete cerebral ischemia in the rat
11. Ketamine effects on local cerebral blood flow and metabolism in the rat
12. The influence of ketamine on both normal and raised intracranial pressure of artificially ventilated animals
13. The effects of anaesthetics upon cerebral circulation and metabolism
14. Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation
15. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death
16. Excitotoxic amino acids and neuropsychiatric disorders
17. Contributory mechanisms in the causation of neurodegenerative disorders
18. Amino acids as dietary excitotoxins: A contribution to understanding neurodegenerative disorders
19. Ganglionic blockade improves neurologic outcome from incomplete ischemia in rats: Partial reversal by exogenous catecholamines
20. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha-2-adrenergic antagonist atipamezole
21. Effect of isoflurane and halothane on in vivo ichemia-induced dopamine release in the corpus striatum of the rat. A study using cerebral microdialysis
22. 2) during hypothermia in rats
23. Noradrenergic modulation of neuronal excitability in mammalian hippocampus
24. Hyperglycemia enlarges infarct size in cerebrovascular occlusion in cats
25. Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion
26. Brain lactate and neurologic outcome following incomplete ischemia in fasted, nonfasted, and glucose-loaded rats
27. Hyperglycemia reduces the extend of cerebral infarction in rats
28. Cerebral and spinal cord blood flow in awake and fentanyl-N2O anesthetized rats: Evidence for preservation of blood flow autoregulation during anesthesia
29. The effects of propofol on brain electrical activity, neurologic outcome, and neuronal damage following incomplete ischemia in rats
30. Effects of anesthetic agents on concentrations of plasma and brain catecholamines during near-complete and incomplete cerebral ischemia